In invasive breast cancer, the interaction of PIWI-like 1 and PIWI-like 2 protein expression was significantly associated with patients’ outcome (OS, DFS, and DDFS) and both markers were significantly associated with molecular subtyping. This evidence concerns the gene PIWIL2 and invasive breast carcinoma.